Paradigm Spine Receives FDA Approval for Spinal Stenosis Device

Paradigm Spine has won FDA premarket approval for its coflex device, a minimally invasive motion-preserving interlaminar stabilization device for spinal stenosis.

Advertisement

A six-year clinical trial of coflex shows shorter hospital stays, faster procedures and improved pain and function compared to patients who underwent pedicle screw fusions.

More Articles on Orthopedic Devices:

Johnson & Johnson Worldwide Medical Device, Diagnostics Sales Reach $7.1B

Brian McCollum to Lead Orthofix Spine Global Business Unit

Lanx Raises $8.7M to Boost Sales of Fusion System, Introduce New Products

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.